Search Results - Stephan Chalon
- Showing 1 - 5 results of 5
-
1
-
2
Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin by Andrea Kuemmerle, Denis Gossen, Annick Janin, Andrew Stokes, Nada Abla, Maja Szramowska, Ulrike Lorch, Myriam El Gaaloul, Isabelle Borghini‐Fuhrer, Stephan Chalon
Published in Clinical and Translational Science (2024-04-01)Get full text
Article -
3
Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predi... by Azrin N. Abd-Rahman, Daniel Kaschek, Anne Kümmel, Rebecca Webster, Adam J. Potter, Anand Odedra, Stephen D. Woolley, Stacey Llewellyn, Lachlan Webb, Louise Marquart, Stephan Chalon, Myriam El Gaaloul, James S. McCarthy, Jörg J. Möhrle, Bridget E. Barber
Published in BMC Medicine (2024-11-01)Get full text
Article -
4
Longitudinal changes in iron homeostasis in human experimental and clinical malariaResearch in context by Stephen D. Woolley, Matthew J. Grigg, Louise Marquart, Jeremy S.E. Gower, Kim Piera, Arya Sheela Nair, Fiona M. Amante, Giri S. Rajahram, Timothy William, David M. Frazer, Stephan Chalon, James S. McCarthy, Nicholas M. Anstey, Bridget E. Barber
Published in EBioMedicine (2024-07-01)Get full text
Article -
5
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development by Aditya H. Gaur, John C. Panetta, Amber M. Smith, Ronald H. Dallas, Burgess B. Freeman, III, Tracy B. Stewart, Li Tang, Elizabeth John, Kristen C. Branum, Nehali D. Patel, Shelley Ost, Ryan N. Heine, Julie L. Richardson, Jared T. Hammill, Lidiya Bebrevska, Fabian Gusovsky, Noritsugu Maki, Toshiharu Yanagi, Patricia M. Flynn, James S. McCarthy, Stephan Chalon, R. Kiplin Guy
Published in EBioMedicine (2022-06-01)Get full text
Article
